Top Markets
Coin of the day
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
Rankning i aktier #14551
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Aktiekurs
$0.87679425
Senast synkroniserad: 2026-08-31
Marknadsvärde
$407.66M
Förändring (1 dag)
-1.88%
Förändring (1 år)
58.03%
Land
SE
Handel Egetis Therapeutics AB (publ) (EGTX)

Kategori

Historik för aktiesplit för Egetis Therapeutics AB (publ) (EGTX)
Aktien Egetis Therapeutics AB (publ) (symbol: EGTX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Sep 01, 2026.
En EGTX-aktie köpt före Sep 01, 2026 motsvarar nu 0 EGTX-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH